Eli Lilly warns of dangerous impurities in knockoff weight-loss drugs. Compounded versions of tirzepatide react with vitamin B12 to form an unknown substance. This untested impurity could pose serious health risks with unknown long-term effects. The FDA has warned about compounded drugs, and Lilly is urging a nationwide recall. The risky market thrives due to high demand, shortages, and high costs of branded drugs. The race for weight-loss solutions has taken another dangerous turn as pharmaceutical giant Eli Lilly issues a public warning about potentially hazardous knockoff versions of its blockbuster drugs. The company revealed that compounded versions of tirzepatide, the active ingredient in…

Newswire

Features

The Latest